Sana Biotechnology, Inc. (SANA) Financials

SANA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 373.6 million 254.4 million
Dec. 31, 2025 416.9 million 256.0 million
Sept. 30, 2025 435.4 million 240.1 million
June 30, 2025 361.6 million 239.1 million

SANA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -37.7 million 5.7 million
Dec. 31, 2025 -33.5 million 6.3 million
Sept. 30, 2025 -29.5 million 5.5 million
June 30, 2025 -33.0 million 6.6 million

SANA Net Income

No data available :(

SANA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 101.1 million 60.5 million 75.3 million
Dec. 31, 2025 138.4 million - 63.9 million
Sept. 30, 2025 153.1 million - 89.7 million
June 30, 2025 72.7 million - 85.5 million

SANA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 276.9 million
Dec. 31, 2025 253.2 million
Sept. 30, 2025 260.5 million
June 30, 2025 238.4 million

SANA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 288000 24.0 million 11.5 million -
Dec. 31, 2025 873000 49.0 million 12.2 million -
Sept. 30, 2025 41000 33.2 million 10.3 million -
June 30, 2025 112000 40.0 million 10.3 million -

SANA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 2.4 million
Dec. 31, 2025 - 3.1 million
Sept. 30, 2025 - -
June 30, 2025 - 2.9 million

SANA

Price: $2.85

52 week price:
2.26
6.55

Earnings Per Share: -0.92 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.2 million

Market Capitalization: 868.3 million

Links: